Related Experiment Video
Updated: Jul 13, 2026
Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Mutational analysis of proapoptotic integrin beta 3 cytoplasmic domain in common human cancers
Nam Jin Yoo1, Young Hwa Soung, Sung Hak Lee
1Department of Pathology, College of Medicine, Catholic University of Korea, Seoul, Korea.
Aims:
Mounting evidence indicates that deregulation of apoptosis is involved in the mechanisms of cancer development. Integrins are cell adhesion receptors that mediate cell survival and migration. A recent study showed that unligated integrin beta 3 (ITGB3) induced apoptosis by recruitment of caspase-8. The aim of the present study was to explore the possibility that genetic alteration of the ITGB3 gene is involved in the development of human cancers possibly by inactivating the apoptosis function of ITGB3.
Methods:
We analyzed the coding region of the cytoplasmic domain of the human ITGB3 gene for the detection of somatic mutations in 100 gastric, 90 colorectal, 100 non-small cell lung, 43 urinary bladder and 50 head-neck cancers by a polymerase chain reaction-based, single-strand conformation polymorphism.
Results:
We found an identical ITGB3 mutation in two unrelated patient samples (one in colorectal and the other in bladder cancer). The ITGB3 mutation was a missense mutation which would substitute an amino acid (E757K).
Conclusions:
The data suggested that the proapoptotic ITGB3 cytoplasmic domain is rarely mutated in common human cancers and may not play an important role in the development of the cancers.
Insights
Genetic mutations in the integrin beta 3 (ITGB3) gene, which can induce apoptosis, were investigated in human cancers. The study found ITGB3 mutations are rare in common cancers, suggesting they may not significantly contribute to cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Deregulation of apoptosis is implicated in cancer development.
- Integrins, like integrin beta 3 (ITGB3), are cell adhesion receptors involved in cell survival and migration.
- Unligated ITGB3 has been shown to induce apoptosis via caspase-8 recruitment.
Purpose of the Study:
- To investigate potential genetic alterations in the ITGB3 gene.
- To determine if ITGB3 gene mutations inactivate its apoptosis function.
- To explore the role of ITGB3 mutations in human cancer development.
Main Methods:
- Analysis of the ITGB3 gene's coding region in the cytoplasmic domain.
- Detection of somatic mutations using polymerase chain reaction-based single-strand conformation polymorphism.
- Study included samples from gastric, colorectal, non-small cell lung, urinary bladder, and head-neck cancers.
Main Results:
- An identical missense mutation (E757K) was identified in two unrelated patients (one colorectal, one bladder cancer).
- This specific mutation was found in a small fraction of the analyzed cancer samples.
- The frequency of ITGB3 mutations across the studied cancer types was low.
Conclusions:
- The proapoptotic ITGB3 cytoplasmic domain appears to be rarely mutated in common human cancers.
- ITGB3 mutations may not play a significant role in the pathogenesis of these cancers.
- Further research could explore other mechanisms involving ITGB3 in cancer.
Related Concept Videos
01:17Intracellular Signaling Affects Focal Adhesions
Some...
01:31The Intrinsic Apoptotic Pathway
01:15Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
01:10Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...